Lionco Pharm Grp Co Ltd (603669) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.108x

Based on the latest financial reports, Lionco Pharm Grp Co Ltd (603669) has a cash flow conversion efficiency ratio of -0.108x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-79.09 Million ≈ $-11.57 Million USD) by net assets (CN¥735.30 Million ≈ $107.60 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Lionco Pharm Grp Co Ltd stock valuation for the company's overall valuation and market capitalisation.

Lionco Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Lionco Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lionco Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lionco Pharm Grp Co Ltd ranked by their cash flow conversion efficiency. Explore Lionco Pharm Grp Co Ltd (603669) cash flow quality to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
ANGLO ASIAN MINING F:A4A	N/A
Blue Moon Metals Inc NASDAQ:BMM	-0.047x
Zhejiang Netsun Co Ltd SHE:002095	0.015x
Guangdong Eastone Century Technology Co Ltd SHE:300310	-0.086x
Shenzhen Water Planning & Design Institute Co. Ltd. SHE:301038	N/A
Tilray Inc NASDAQ:TLRY	-0.023x
Citra Marga Nusaphala Persada JK:CMNP	0.004x
Ackerstein Group Ltd TA:ACKR	-0.026x

Annual Cash Flow Conversion Efficiency for Lionco Pharm Grp Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Lionco Pharm Grp Co Ltd from 2011 to 2025. View Lionco Pharm Grp Co Ltd share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥620.28 Million ≈ $90.77 Million	CN¥-132.87 Million ≈ $-19.44 Million	-0.214x	-48.69%
2024-12-31	CN¥769.76 Million ≈ $112.64 Million	CN¥-110.89 Million ≈ $-16.23 Million	-0.144x	-254.12%
2023-12-31	CN¥931.04 Million ≈ $136.24 Million	CN¥-37.87 Million ≈ $-5.54 Million	-0.041x	+30.41%
2022-12-31	CN¥1.14 Billion ≈ $166.11 Million	CN¥-66.36 Million ≈ $-9.71 Million	-0.058x	-166.36%
2021-12-31	CN¥1.46 Billion ≈ $213.47 Million	CN¥128.50 Million ≈ $18.80 Million	0.088x	+2.79%
2020-12-31	CN¥1.48 Billion ≈ $216.55 Million	CN¥126.81 Million ≈ $18.56 Million	0.086x	-52.21%
2019-12-31	CN¥1.31 Billion ≈ $192.25 Million	CN¥235.61 Million ≈ $34.48 Million	0.179x	+32.94%
2018-12-31	CN¥1.38 Billion ≈ $201.64 Million	CN¥185.87 Million ≈ $27.20 Million	0.135x	-7.27%
2017-12-31	CN¥1.30 Billion ≈ $190.12 Million	CN¥189.01 Million ≈ $27.66 Million	0.145x	-6.66%
2016-12-31	CN¥1.17 Billion ≈ $171.13 Million	CN¥182.27 Million ≈ $26.67 Million	0.156x	+76.47%
2015-12-31	CN¥1.12 Billion ≈ $163.82 Million	CN¥98.88 Million ≈ $14.47 Million	0.088x	-81.79%
2014-12-31	CN¥374.13 Million ≈ $54.75 Million	CN¥181.50 Million ≈ $26.56 Million	0.485x	+5.92%
2013-12-31	CN¥351.02 Million ≈ $51.37 Million	CN¥160.77 Million ≈ $23.53 Million	0.458x	-24.13%
2012-12-31	CN¥236.22 Million ≈ $34.57 Million	CN¥142.61 Million ≈ $20.87 Million	0.604x	-20.99%
2011-12-31	CN¥128.55 Million ≈ $18.81 Million	CN¥98.23 Million ≈ $14.37 Million	0.764x	--

About Lionco Pharm Grp Co Ltd

SHG:603669 China Drug Manufacturers - Specialty & Generic

Market Cap

$549.33 Million

CN¥3.75 Billion CNY

Market Cap Rank

#11789 Global

#3353 in China

Share Price

CN¥5.27

Change (1 day)

+0.38%

52-Week Range

CN¥4.05 - CN¥8.11

All Time High

CN¥12.67